Teleflex Completes Patient Enrollment In BIOMAG-LL Clinical Study, Evaluating Freesolve RMS In 35 mm And 40 mm Lengths For Treatment Of De Novo Coronary Lesions Up To 38 mm

뉴스 본문을 불러오고 있어요.

Teleflex Completes Patient Enrollment In BIOMAG-LL Clinical Study, Evaluating Freesolve RMS In 35 mm And 40 mm Lengths For Treatment Of De Novo Coronary Lesions Up To 38 mm | 웨이프 WAPE

Teleflex Completes Patient Enrollment In BIOMAG-LL Clinical Study, Evaluating Freesolve RMS In 35 mm And 40 mm Lengths For Treatment Of De Novo Coronary Lesions Up To 38 mm

기사 요약

관련 종목

댓글 —